These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29565196)

  • 1. Developing an instrument to assess patient preferences for benefits and risks of treating acute myeloid leukemia to promote patient-focused drug development.
    Seo J; Smith BD; Estey E; Voyard E; O' Donoghue B; Bridges JFP
    Curr Med Res Opin; 2018 Dec; 34(12):2031-2039. PubMed ID: 29565196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing and piloting an instrument to prioritize the worries of patients with acute myeloid leukemia.
    Bridges JF; Oakes AH; Reinhart CA; Voyard E; O'Donoghue B
    Patient Prefer Adherence; 2018; 12():647-655. PubMed ID: 29731612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age at Diagnosis and Patient Preferences for Treatment Outcomes in AML: A Discrete Choice Experiment to Explore Meaningful Benefits.
    Richardson DR; Crossnohere NL; Seo J; Estey E; O'Donoghue B; Smith BD; Bridges JFP
    Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):942-948. PubMed ID: 32132149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy.
    Peay HL; Hollin I; Fischer R; Bridges JF
    Clin Ther; 2014 May; 36(5):624-37. PubMed ID: 24852596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side effects from acute myeloid leukemia treatment: results from a national survey.
    Crossnohere NL; Richardson DR; Reinhart C; O'Donoghue B; Love SM; Smith BD; Bridges JFP
    Curr Med Res Opin; 2019 Nov; 35(11):1965-1970. PubMed ID: 31188058
    [No Abstract]   [Full Text] [Related]  

  • 6. Prioritizing the worries of AML patients: Quantifying patient experience using best-worst scaling.
    Richardson DR; Oakes AH; Crossnohere NL; Rathsmill G; Reinhart C; O'Donoghue B; Bridges JFP
    Psychooncology; 2021 Jul; 30(7):1104-1111. PubMed ID: 33544421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Do Members of the Duchenne and Becker Muscular Dystrophy Community Perceive a Discrete-Choice Experiment Incorporating Uncertain Treatment Benefit? An Application of Research as an Event.
    Bridges JFP; Tsai JH; Janssen E; Crossnohere NL; Fischer R; Peay H
    Patient; 2019 Apr; 12(2):247-257. PubMed ID: 30259384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Care Management for Youth With Comorbid Developmental and Mental Health Conditions: A Discrete Choice Experiment Pilot Study.
    dosReis S; N'Dri L; Ross M; Camelo Castillo W; Reeves G; Butler B
    Acad Pediatr; 2020 Mar; 20(2):241-249. PubMed ID: 31128382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient preferences for heart valve disease intervention.
    Fifer S; Keen B; Guilbert-Wright P; Yamabe K; Murdoch DJ
    Health Expect; 2024 Feb; 27(1):e13929. PubMed ID: 38050462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the experience, treatment preferences and goals of people living with chronic lymphocytic leukemia (CLL) in Australia.
    Fifer S; Godsell J; Opat S; Hamad N; Lasica M; Forsyth C; Morand L; Smeaton E; Winton S; Puig A; McGeachie M
    BMC Cancer; 2024 Jul; 24(1):831. PubMed ID: 38992616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Framework for Instrument Development of a Choice Experiment: An Application to Type 2 Diabetes.
    Janssen EM; Segal JB; Bridges JF
    Patient; 2016 Oct; 9(5):465-79. PubMed ID: 27120338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient and caregiver preferences for the potential benefits and risks of a seizure forecasting device: A best-worst scaling.
    Janse SA; Dumanis SB; Huwig T; Hyman S; Fureman BE; Bridges JFP
    Epilepsy Behav; 2019 Jul; 96():183-191. PubMed ID: 31150998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferences of patients and physicians in the United States for relapsed/refractory follicular lymphoma treatments.
    Thomas C; Marsh K; Trapali M; Krucien N; Worth G; Cockrum P; Lycett D
    Cancer Med; 2024 Oct; 13(19):e70177. PubMed ID: 39394846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient preferences, regret, and health-related quality of life among older adults with acute myeloid leukemia: A pilot longitudinal study.
    LoCastro M; Wang Y; Sanapala C; Jensen-Battaglia M; Wittink M; Norton S; Klepin HD; Richardson DR; Mendler JH; Liesveld J; Huselton E; Loh KP
    J Geriatr Oncol; 2023 Jun; 14(5):101529. PubMed ID: 37244139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival or Mortality: Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?
    Veldwijk J; Essers BA; Lambooij MS; Dirksen CD; Smit HA; de Wit GA
    Value Health; 2016; 19(2):202-9. PubMed ID: 27021754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Line of therapy and patient preferences regarding lung cancer treatment: a discrete-choice experiment.
    Janse S; Janssen E; Huwig T; Basu Roy U; Ferris A; Presley CJ; Bridges JFP
    Curr Med Res Opin; 2021 Apr; 37(4):643-653. PubMed ID: 33571024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients' Preferences for the Treatment of Metastatic Castrate-resistant Prostate Cancer: A Discrete Choice Experiment.
    Eliasson L; de Freitas HM; Dearden L; Calimlim B; Lloyd AJ
    Clin Ther; 2017 Apr; 39(4):723-737. PubMed ID: 28366592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Systematic and Critical Review of Discrete Choice Experiments in Asthma and Chronic Obstructive Pulmonary Disease.
    Collacott H; Zhang D; Heidenreich S; Tervonen T
    Patient; 2022 Jan; 15(1):55-68. PubMed ID: 34250574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-centered communication tool for older patients with acute myeloid leukemia, their caregivers, and oncologists: A single-arm pilot study.
    LoCastro M; Sanapala C; Wang Y; Jensen-Battaglia M; Wittink M; Norton S; Klepin HD; Richardson DR; Mendler JH; Liesveld J; Huselton E; O'Dwyer K; Cortes AM; Rodriguez C; Dale W; Loh KP
    Cancer Med; 2023 Apr; 12(7):8581-8593. PubMed ID: 36533397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Centered Insights on Treatment Decision Making and Living with Acute Myeloid Leukemia and Other Hematologic Cancers.
    Crawford R; Sully K; Conroy R; Johnson C; Doward L; Bell T; Welch V; Peloquin F; Gater A
    Patient; 2020 Feb; 13(1):83-102. PubMed ID: 31456136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.